Horizon Discovery Group Plc (HZD)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Horizon Discovery Group Plc (HZD)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH132463D
  • |
  • Pages: 78
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Horizon Discovery Group plc (Horizon Discovery) is a life science company that provides enabling products, services and research programs. The company provides rAAV, ZFN and CRISPR custom cell line and in vivo model generation services for research and bio production applications. It offers quantitative molecular reference standards, in vivo disease models, contract research and custom screening services for target identification and validation, and for drug combination studies. Horizon Discovery's research services include immuno oncology platform, functional genomic screening, drug combination screening, and in vitro assay and in vivo services. The company has its presence in Austria, the UK and the US. Horizon Discovery is headquartered in Cambridge, the UK.

Horizon Discovery Group Plc (HZD)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 6

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10

Horizon Discovery Group Plc, Medical Devices Deals, 2011 to YTD 2017 11

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deal Details 16

Asset Purchase 16

Horizon Discovery Completes Acquisition of Combination High Throughput Screening from Zalicus 16

Venture Financing 17

Horizon Discovery Raises US$10.5 Million In Final Closing Of Series C Financing 17

Horizon Discovery Raises US$17.9 Million In Series C Financing 18

Partnerships 19

Horizon Discovery Enters Into Licensing Agreement With ATCC 19

Horizon Discovery Enters into Research Agreement with Solentim 20

Horizon Discovery Enters into Agreement with Fulcrum Therapeutics 21

Horizon Discovery Enters into Agreement with Ubiquigent 21

Horizon Discovery Forms Joint Venture with Centauri Therapeutics 22

Horizon Discovery Partners with Axol Bioscience 23

Horizon Discovery Enters into Agreement with Swift Biosciences 24

Horizon Discovery Enters into Research Agreement with Redx Pharma 25

Horizon Discovery Enters into Co-Development Agreement with DefiniGEN 25

CareDx Enters into Co-Development Agreement with Horizon Discovery 26

Horizon Discovery Enters into Agreement with Thermo Fisher Scientific 27

Horizon Discovery Enters into Distribution Agreement with Thermo Fisher 28

Horizon Discovery Enters into Distribution Agreement with Haplogen Genomics 28

Horizon Discovery Enters into Development and Commercialization Agreement with Otsuka Pharma 29

Horizon Discovery Enters Into Co-Development Agreement With Desktop Genetics 30

Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 31

Horizon Discovery Enters Into R&D Agreement With UCL Institute of Neurology For rAAV-mediated Genome Editing 32

Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 32

Horizon Discovery Enters Into Agreement With Domainex To Support Oncology Program 33

Horizon Discovery Enters Into Co-Development Agreement With Bayer Pharma For Human Isogenic Cell Lines 34

Horizon Discovery Enters Into Co-Development Agreement With H3 Biomedicine 35

Horizon Discovery Enters Into Joint Venture Agreement With Fox Chase Cancer 36

Horizon Discovery Enters Into Co-Development Agreement With University Of Washington 37

Licensing Agreements 38

Horizon Discovery Group Enters into Licensing Agreement with AmplyCell 38

Horizon Discovery Extends Licensing Agreement with ERS Genomics 39

Horizon Discovery Group Enters into Licensing Agreement 40

Horizon Discovery Enters into Licensing Agreement with Wistar Institute 41

Horizon Discovery Enters into Licensing Agreement with ProteoNic 41

Horizon Discovery Enters into Licensing Agreement with Servier Lab 42

LakePharma Enters into Licensing Agreement with Horizon Discovery 43

Abcam Enters into Licensing Agreement with Horizon Discovery 44

Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 45

Horizon Discovery Enters into Licensing Agreement with Stanford University 46

Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 46

Horizon Discovery Enters Into Licensing Agreement With AstraZeneca 47

Horizon Discovery Enters Into Licensing Agreement With Harvard University For Crispr Gene Editing Technology 48

Sigma-Aldrich Enters Into Licensing Agreement With Horizon Discovery For CompoZr Zinc Finger Nuclease Technology 49

Horizon Discovery And AstraZeneca Enter Into Licensing Agreement To Develop Cancer Therapies 50

NIH Center for Regenerative Medicine Enters Into Licensing Agreement With Horizon Discovery For Genesis Technology 52

Horizon Discovery Enters Into Licensing Agreement With Rosalind Franklin University of Medicine and Science 52

Horizon Discovery Enters Into Licensing Agreement With University Of Minnesota 53

Horizon Discovery Enters Into Licensing Agreement With Yokohama City University For X-MAN Cell Lines 54

Horizon Discovery Enters Into Licensing Agreement With University Of Pittsburgh 55

Horizon Discovery Enters Into Licensing Agreement With The University of Minnesota 56

Equity Offering 57

Horizon Discovery Raises USD38.5 Million in Private Placement of Shares 57

Horizon Discovery Completes IPO For US$66.7 Million 58

Acquisition 59

Horizon Discovery to Acquire Haplogen Genomics for USD15 Million 59

Horizon Discovery to Acquire Sage Labs for USD48 Million 60

Horizon Discovery Group Plc-Key Competitors 62

Key Employees 63

Locations And Subsidiaries 64

Head Office 64

Other Locations & Subsidiaries 64

Recent Developments 65

Financial Announcements 65

Sep 20, 2016: Horizon Discovery Group Announces Interim Results for the Six Months Ended 30 June 2016 65

Sep 20, 2016: Horizon Discovery Group interim results for the six months ended 30 June 2016 67

Apr 26, 2016: Horizon Discovery Group: Preliminary Results for the Year Ended 31 December 2015 69

Product News 70

Apr 15, 2016: Horizon Discovery Introduces High Throughput Platform for Immuno-Oncology Research 70

Mar 22, 2016: Horizon Discovery Group Launches HDx RNA Fusion Reference Standards 71

Mar 09, 2016: Horizon Discovery introduces Microinjection-Ready Cas9 Accelerate Ribonucleoprotein 72

Other Significant Developments 73

Jan 24, 2017: Horizon Discovery Group: Trading Update 73

Dec 20, 2016: Horizon Discovery provides operation update on catalogue cell line business 74

Dec 14, 2016: Horizon Discovery Announces a Progress Update on its Biomanufacturing Business 75

Nov 01, 2016: Horizon Discovery Announces a Progress Update on its High-throughput Molecular Screening Platform 76

Jan 18, 2016: Horizon Discovery Provides Trading Update 77

Appendix 78

Methodology 78

About GlobalData 78

Contact Us 78

Disclaimer 78

List of Figures

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 8

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10

Horizon Discovery Group Plc, Medical Devices Deals, 2011 to YTD 2017 11

List of Tables

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9

Horizon Discovery Group Plc, Deals By Therapy Area, 2011 to YTD 2017 10

Horizon Discovery Group Plc, Medical Devices Deals, 2011 to YTD 2017 11

Horizon Discovery Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12

Horizon Discovery Completes Acquisition of Combination High Throughput Screening from Zalicus 16

Horizon Discovery Raises US$10.5 Million In Final Closing Of Series C Financing 17

Horizon Discovery Raises US$17.9 Million In Series C Financing 18

Horizon Discovery Enters Into Licensing Agreement With ATCC 19

Horizon Discovery Enters into Research Agreement with Solentim 20

Horizon Discovery Enters into Agreement with Fulcrum Therapeutics 21

Horizon Discovery Enters into Agreement with Ubiquigent 21

Horizon Discovery Forms Joint Venture with Centauri Therapeutics 22

Horizon Discovery Partners with Axol Bioscience 23

Horizon Discovery Enters into Agreement with Swift Biosciences 24

Horizon Discovery Enters into Research Agreement with Redx Pharma 25

Horizon Discovery Enters into Co-Development Agreement with DefiniGEN 25

CareDx Enters into Co-Development Agreement with Horizon Discovery 26

Horizon Discovery Enters into Agreement with Thermo Fisher Scientific 27

Horizon Discovery Enters into Distribution Agreement with Thermo Fisher 28

Horizon Discovery Enters into Distribution Agreement with Haplogen Genomics 28

Horizon Discovery Enters into Development and Commercialization Agreement with Otsuka Pharma 29

Horizon Discovery Enters Into Co-Development Agreement With Desktop Genetics 30

Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 31

Horizon Discovery Enters Into R&D Agreement With UCL Institute of Neurology For rAAV-mediated Genome Editing 32

Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 32

Horizon Discovery Enters Into Agreement With Domainex To Support Oncology Program 33

Horizon Discovery Enters Into Co-Development Agreement With Bayer Pharma For Human Isogenic Cell Lines 34

Horizon Discovery Enters Into Co-Development Agreement With H3 Biomedicine 35

Horizon Discovery Enters Into Joint Venture Agreement With Fox Chase Cancer 36

Horizon Discovery Enters Into Co-Development Agreement With University Of Washington 37

Horizon Discovery Group Enters into Licensing Agreement with AmplyCell 38

Horizon Discovery Extends Licensing Agreement with ERS Genomics 39

Horizon Discovery Group Enters into Licensing Agreement 40

Horizon Discovery Enters into Licensing Agreement with Wistar Institute 41

Horizon Discovery Enters into Licensing Agreement with ProteoNic 41

Horizon Discovery Enters into Licensing Agreement with Servier Lab 42

LakePharma Enters into Licensing Agreement with Horizon Discovery 43

Abcam Enters into Licensing Agreement with Horizon Discovery 44

Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 45

Horizon Discovery Enters into Licensing Agreement with Stanford University 46

Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 46

Horizon Discovery Enters Into Licensing Agreement With AstraZeneca 47

Horizon Discovery Enters Into Licensing Agreement With Harvard University For Crispr Gene Editing Technology 48

Sigma-Aldrich Enters Into Licensing Agreement With Horizon Discovery For CompoZr Zinc Finger Nuclease Technology 49

Horizon Discovery And AstraZeneca Enter Into Licensing Agreement To Develop Cancer Therapies 50

NIH Center for Regenerative Medicine Enters Into Licensing Agreement With Horizon Discovery For Genesis Technology 52

Horizon Discovery Enters Into Licensing Agreement With Rosalind Franklin University of Medicine and Science 52

Horizon Discovery Enters Into Licensing Agreement With University Of Minnesota 53

Horizon Discovery Enters Into Licensing Agreement With Yokohama City University For X-MAN Cell Lines 54

Horizon Discovery Enters Into Licensing Agreement With University Of Pittsburgh 55

Horizon Discovery Enters Into Licensing Agreement With The University of Minnesota 56

Horizon Discovery Raises USD38.5 Million in Private Placement of Shares 57

Horizon Discovery Completes IPO For US$66.7 Million 58

Horizon Discovery to Acquire Haplogen Genomics for USD15 Million 59

Horizon Discovery to Acquire Sage Labs for USD48 Million 60

Horizon Discovery Group Plc, Key Competitors 62

Horizon Discovery Group Plc, Key Employees 63

Horizon Discovery Group Plc, Subsidiaries 64

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Horizon Discovery Group Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16143
Site License
USD 500 INR 32285
Corporate User License
USD 750 INR 48428

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com